Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
Open accessAbstract
The prevalence of patients with concomitant heart failure (HF) and diabetes mellitus (DM) continues to increase with the general aging of the population. In patients with chronic HF, prevalence of DM is 24% compared with 40% in those hospitalized with worsening HF. Patients with concomitant HF and DM have diverse pathophysiologic, metabolic, and neurohormonal abnormalities that potentially contribute to worse outcomes than those without comorbid DM. In addition, although stable HF outpatients with DM show responses that are similar to those of patients without DM undergoing evidence-based therapies, it is unclear whether hospitalized HF patients with DM will respond similarly to novel investigational therapies. These data support the need to re-evaluate the epidemiology, pathophysiology, and therapy of HF patients with concomitant DM. This paper discusses the role of DM in HF patients and underscores the potential need for the development of targeted therapies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
T2DM increases the incidence of HF up to more than double with respect to non-affected individuals, and this complication may develop independently of coronary artery disease and associated risk factors.
“Since the report of the Framingham Heart study, type 2 diabetes (T2DM) has been known to increase the incidence of HF up to more than double with respect to non-affected individuals, with the growing awareness that this complication may develop independently of coronary artery disease (CAD) and associated risk factors [8,9,10,11].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [10]
Eplerenone seems to have no effect on new-onset T2DM in patients with HF, suggesting a neutral metabolic profile.
“Importantly, eplerenone seems to have no effect on new-onset T2DM in patients with HF, suggesting a neutral metabolic profile.160”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works
Self-citationThe Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214 · see citing works
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941 · see citing works
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129 · see citing works
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · see citing works
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304 · see citing works
Self-citationA Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108 · see citing works
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927 · see citing works
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502 · see citing works
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,180 · see citing works
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636 · see citing works
Home, P. D., Pocock, S. J., Beck-Nielsen, H., Curtis, P. S., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60953-3 · Cited by 1,393 · see citing works
Packer, M., Fowler, M. B., Roecker, E. B., Coats, A. J. S., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Staiger, C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035653.72855.bf · Cited by 1,364 · see citing works
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319 · see citing works
Nieminen, M. S., Brutsaert, D. L., Dickstein, K., Drexler, H., Folláth, F., Harjola, V., Hochadel, M., Michel Komajda, N., Lassus, J. P. E., Lopez-Sendon, J. L., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl193 · Cited by 1,292 · see citing works
Forman, D. E., Butler, J., Wang, Y., Abraham, W. T., O’Connor, C. M., Gottlieb, S. S., Loh, E., Massie, B. M., Rich, M. W., Stevenson, L. W., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.031 · Cited by 909 · see citing works
Self-citationThe Incidence of Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A., & Brown, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1879 · Cited by 812 · see citing works
Rehospitalization for Heart Failure
Gheorghiade, M., Vaduganathan, M., Fonarow, G. C., & Bonow, R. O. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.038 · Cited by 733 · see citing works
Self-citationGlycemic Control and Heart Failure Among Adult Patients With Diabetes
Iribarren, C., Karter, A. J., Go, A. S., Ferrara, A. M., Liu, J. Y., Sidney, S. S., & Selby, J. V. (2001) · Circulation · doi:10.1161/01.cir.103.22.2668 · Cited by 703 · see citing works
MacDonald, M. R., Petrie, M. C., Varyani, F., Ostergren, J., Michelson, E. L., Young, J. B., Solomon, S. D., Granger, C. B., Swedberg, K., Yusuf, S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn153 · Cited by 694 · see citing works
Return to the fetal gene program protects the stressed heart: a strong hypothesis
Rajabi, M., Kassiotis, C., Razeghi, P., & Taegtmeyer, H. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9034-1 · Cited by 425 · see citing works
Young, J. B., Dunlap, M. E., Pfeffer, M. A., Probstfield, J. L., Solal, A. C., Dietz, R., Granger, C. B., Hradec, J., Kuch, J., McKelvie, R. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146819.43235.a9 · Cited by 397 · see citing works
Heart Failure–Associated Hospitalizations in the United States
Blecker, S., Paul, M. M., Taksler, G. B., Ogedegbe, G. G., & Katz, S. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.038 · Cited by 392 · see citing works
Gheorghiade, M., Böhm, M., Greene, S. J., Fonarow, G. C., Lewis, E. F., Zannad, F. M., Solomon, S. D., Baschiera, F., Botha, J., Hua, T. A., et al. (2013) · JAMA · doi:10.1001/jama.2013.1954 · Cited by 325 · see citing works
Self-citationAlbuminuria in chronic heart failure: prevalence and prognostic importance
Jackson, C. E., Solomon, S. D., Gerstein, H. C., Zetterstrand, S., Olofsson, B., Michelson, E. L., Granger, C. B., Swedberg, K. B., Pfeffer, M. A., Yusuf, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61378-7 · Cited by 308 · see citing works
Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I. F., von Haehling, S., Okonko, D. O., Leyva, F., Proudler, A. J., Coats, A. J. S., & Anker, S. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.093 · Cited by 294 · see citing works
Self-citation2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 290 · see citing works
Self-citationGustafsson, I., Brendorp, B., Seibæk, M., Burchardt, H., Hildebrandt, P., Køber, L., & Torp-Pedersen, C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.024 · Cited by 258 · see citing works
The role of the kidney in heart failure
Metra, M., Cotter, G., Gheorghiade, M., Cas, L. D., & Voors, A. A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs205 · Cited by 257 · see citing works
Self-citationThe effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Domanski, M., Krause-Steinrauf, H., Deedwania, P., Follmann, D., Ghali, J. K., Gilbert, E., Haffner, S., Katz, R., Lindenfeld, J., Lowes, B. D., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00856-8 · Cited by 215 · see citing works
Sarma, S., Mentz, R. J., Kwasny, M. J., Fought, A. J., Huffman, M., Subacius, H., Nodari, S., Konstam, M., Swedberg, K., Maggioni, A. P., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs153 · Cited by 202 · see citing works
Greenberg, B. H., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O'Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.001 · Cited by 196 · see citing works
Self-citationHaas, S. J., Vos, T., Gilbert, R. E., & Krum, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00403-4 · Cited by 194 · see citing works
Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials
Monami, M., Dicembrini, I., & Mannucci, E. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.017 · Cited by 191 · see citing works
Erland, E., Philippe, L., Patricia, V., & Hermann, W. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00174-x · Cited by 190 · see citing works
Cherian, S., Lopaschuk, G. D., & Carvalho, E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00061.2012 · Cited by 185 · see citing works
RYDEN, L. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2311 · Cited by 174 · see citing works
Torp-Pedersen, C., Metra, M., Charlesworth, A., Spark, P., Lukas, M. A., Poole-Wilson, P. A., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Remme, W. J., et al. (2007) · Heart · doi:10.1136/hrt.2006.092379 · Cited by 171 · see citing works
Solini, A., Penno, G., Bonora, E., Fondelli, C., Orsi, E., Arosio, M., Trevisan, R., Vedovato, M., Cignarelli, M., Andreozzi, F., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1380 · Cited by 144 · see citing works
Deedwania, P. C., Giles, T. D., Klibaner, M., Ghali, J. K., Herlitz, J., Hildebrandt, P., Kjekshus, J., Spinar, J., Vitovec, J., Stanbrook, H., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.05.056 · Cited by 143 · see citing works
Gustafsson, I., Torp-Pedersen, C. T., Køber, L., Gustafsson, F., & Hildebrandt, P. R. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00146-1 · Cited by 135 · see citing works
von Bibra, H., Hansen, A., Dounis, V., Bystedt, T., Malmberg, K., & Rydén, L. (2004) · Heart · doi:10.1136/hrt.2003.020842 · Cited by 116 · see citing works
Teshima, Y., Takahashi, N., Saikawa, T., Hara, M., Yasunaga, S., Hidaka, S., & Sakata, T. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1107 · Cited by 109 · see citing works
Carr, A. A., Kowey, P. R., Devereux, R. B., Brenner, B. M., Dahlöf, B., Ibsen, H., Lindholm, L. H., Lyle, P. A., Snapinn, S. M., Zhang, Z., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.061 · Cited by 107 · see citing works
Uniformity of captopril benefit in the SAVE study: subgroup analysis
Moyé, L. A., Pfeffer, M. A., Wun, C. C., Davis, B. R., Geltman, E. M., Hayes, D. L., Farnham, D. J., Randall, O. S., Dinh, H., Arnold, J. M. O., et al. (1994) · European Heart Journal · doi:10.1093/eurheartj/15.suppl_b.2 · Cited by 107 · see citing works
Regulation of contractile proteins in diabetic heart
Malhotra, A. K. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00059-x · Cited by 94 · see citing works
Greenberg, B., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O’Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.08.002 · Cited by 76 · see citing works
Self-citationCardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
Metra, M., Zacà, V., Parati, G., Agostoni, P., Bonadies, M., Ciccone, M. M., Dei, A., Iacoviello, M., Lagioia, R., Lombardi, C., et al. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834058d1 · Cited by 72 · see citing works
Decreased High-Energy Phosphate Ratios in the Myocardium of Men with Diabetes Mellitus Type I
Metzler, B., Schocke, M. F. H., Steinboeck, P., Wolf, C., Judmaier, W., Lechleitner, M., Lukas, P. H., & Pachinger, O. M. (2002) · Journal of Cardiovascular Magnetic Resonance · doi:10.1081/jcmr-120016387 · Cited by 67 · see citing works
Maggioni, A. P., Greene, S. J., Fonarow, G. C., Böhm, M., Zannad, F. M., Solomon, S. D., Lewis, E. F., Baschiera, F., Hua, T., Gimpelewicz, C. R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht342 · Cited by 55 · see citing works
Self-citationAntioxidants and Myocardial Contractility
Givertz, M. M., Sawyer, D. B., & Colucci, W. S. (2001) · Circulation · doi:10.1161/01.cir.103.6.782 · Cited by 43 · see citing works
Butler, J., Fonarow, G. C., & Gheorghiade, M. (2013) · JAMA · doi:10.1001/jama.2013.282815 · Cited by 41 · see citing works
Self-citationHeat Shock Protein 27 Modification is Increased in the Human Diabetic Failing Heart
Gawlowski, T., Stratmann, B., Stork, I., Engelbrecht, B., Brodehl, A., Niehaus, K. E., Körfer, R., Tschoepe, D., & Milting, H. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1216374 · Cited by 36 · see citing works
Self-citationBorghi, C., Ambrosioni, E., & Magnani, B. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00285-8 · Cited by 29 · see citing works
Bassand, J. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060374 · Cited by 28 · see citing works
Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure
Kapoor, J. R., Fonarow, G. C., Zhao, X., Kapoor, R., Hernandez, A. F., & Heidenreich, P. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.008 · Cited by 26 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215 · see citing works
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,183 · see citing works
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708 · see citing works
Self-citationHeart Failure in Type 2 Diabetes Mellitus
Kenny, H., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 671 · see citing works
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000691 · Cited by 639 · see citing works
Self-citationThe cardio-renal-metabolic connection: a review of the evidence
Marassi, M., & Fadini, G. P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01937-x · Cited by 386 · see citing works
Heart Failure With Preserved Ejection Fraction and Diabetes
McHugh, K., DeVore, A. D., Wu, J., Matsouaka, R. A., Fonarow, G. C., Heidenreich, P. A., Yancy, C. W., Green, J. B., Altman, N., & Hernandez, A. F. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.033 · Cited by 313 · see citing works
Self-citationNew Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
de Lucia, C., Eguchi, A., & Koch, W. J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00904 · Cited by 277 · see citing works
Reframing the Association and Significance of Co-Morbidities in Heart Failure
Triposkiadis, F. K., Giamouzis, G., Parissis, J., Starling, R. C., Boudoulas, H. K., Skoularigis, J. S., Butler, J., & Filippatos, G. S. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.600 · Cited by 232 · see citing works
Self-citationMetabolic Origins of Heart Failure
Wende, A. R., Brahma, M. K., McGinnis, G. R., & Young, M. E. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.11.009 · Cited by 208 · see citing works
Targher, G., Dauriz, M., Laroche, C., Temporelli, P. L., Hassanein, M., Seferovic, P. M., Drozdz, J., Ferrari, R., Anker, S., Coats, A., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.679 · Cited by 169 · see citing works
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
Evangelista, I., Nuti, R., Picchioni, T., Dotta, F., & Palazzuoli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133264 · Cited by 170 · see citing works
Cardoso, R. N., Graffunder, F. P., Ternes, C. M. P., Fernandes, A. D. F., Rocha, A. V., Fernandes, G. C., & Bhatt, D. L. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100933 · Cited by 165 · see citing works
Mitochondria and oxidative stress in heart aging
Martín‐Fernández, B., & Gredilla, R. (2016) · AGE · doi:10.1007/s11357-016-9933-y · Cited by 155 · see citing works
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.05.007 · Cited by 145 · see citing works
Self-citationDauriz, M., Targher, G., Laroche, C., Temporelli, P. L., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M., Mebazaa, A., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2016 · Cited by 139 · see citing works
Coronary microvascular dysfunction in diabetes mellitus
Kibel, A., Selthofer-Relatić, K., Drenjančević, I., Bačun, T., Bošnjak, I., Kibel, D., & Gros, M. (2017) · Journal of International Medical Research · doi:10.1177/0300060516675504 · Cited by 141 · see citing works
Khan, M. S., Fonarow, G. C., McGuire, D. K., Hernandez, A. F., Vaduganathan, M., Rosenstock, J., Handelsman, Y., Verma, S., Anker, S. D., McMurray, J. J. V., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045888 · Cited by 139 · see citing works
Self-citationThe role of metabolic syndrome in heart failure
Filardi, P. P., Paolillo, S., Costanzo, P., Savarese, G., Trimarco, B., & Bonow, R. O. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv350 · Cited by 130 · see citing works
Self-citationType 2 Diabetes and Heart Failure: Challenges and Solutions
Thomas, M. C. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160606120254 · Cited by 119 · see citing works
Palazzuoli, A., & Iacoviello, M. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10238-6 · Cited by 122 · see citing works
PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction
Dalt, L. D., Castiglioni, L., Baragetti, A., Audano, M., Svecla, M., Bonacina, F., Pedretti, S., Uboldi, P., Benzoni, P., Giannetti, F., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab431 · Cited by 118 · see citing works
von Haehling, S., Arzt, M. E., Doehner, W., Edelmann, F., Evertz, R., Ebner, N., Herrmann‐Lingen, C., Garfias‐Veitl, T., Koziolek, M. J., Noutsias, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1838 · Cited by 116 · see citing works
Self-citationImpact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
Palmiero, G., Cesaro, A., Vetrano, E., Pafundi, P. C., Galiero, R., Caturano, A., Moscarella, E., Gragnano, F., Salvatore, T., Rinaldi, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115863 · Cited by 120 · see citing works
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
FITCHETT, D. H., Udell, J. A., & Inzucchi, S. E. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.633 · Cited by 102 · see citing works
Jannapureddy, S., Sharma, M., Yepuri, G., Schmidt, A. M., & Ramasamy, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.636267 · Cited by 104 · see citing works
Tanaka, A., Hisauchi, I., Taguchi, I., Sezai, A., Toyoda, S., Tomiyama, H., Sata, M., Ueda, S., Oyama, J., Kitakaze, M., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12707 · Cited by 101 · see citing works
SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes
Wu, X., Liu, H., Brooks, A. C., Xu, S., Luo, J., Steiner, R., Mickelsen, D. M., Moravec, C. S., Alexis, J. D., Small, E. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.318988 · Cited by 98 · see citing works
Mason, T., Coelho‐Filho, O. R., Verma, S., Chowdhury, B., Zuo, F., Quan, A., Thorpe, K. E., Bonneau, C., Teoh, H., Gilbert, R. E., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.10.017 · Cited by 96 · see citing works
Dias, I. C. D. S., Carabelli, B., Ishii, D. K., Morais, H., de Carvalho, M. C., de Souza, L. E. R., Zanata, S. M., Brandão, M. L., Cunha, T. M., Ferraz, A. C., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9617-0 · Cited by 86 · see citing works
Sharma, A., Green, J. B., Dunning, A., Lokhnygina, Y., Al-Khatib, S. M., Lopes, R. D., Buse, J. B., Lachin, J. M., Van de Werf, F., Armstrong, P. W., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1091 · Cited by 80 · see citing works
Komajda, M., Tavazzi, L., Francq, B. G., Böhm, M., Borer, J. S., Ford, I., & Swedberg, K. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.347 · Cited by 76 · see citing works
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
Mohan, M., Dihoum, A., Mordi, I. R., Choy, A. M., Rena, G., & Lang, C. C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.746382 · Cited by 70 · see citing works
Dauriz, M., Targher, G., Temporelli, P. L., Lucci, D., Gonzini, L., Nicolosi, G. L., Marchioli, R., Tognoni, G., Latini, R., Cosmi, F., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005156 · Cited by 70 · see citing works
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
Molinaro, A., Nemet, I., Lassen, P. B., Chakaroun, R., Nielsen, T., Aron‐Wisnewsky, J., Bergh, P., Li, L., Henricsson, M., Køber, L., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.03.008 · Cited by 70 · see citing works
Cooper, L. B., Benson, L., Mentz, R. J., Savarese, G., DeVore, A. D., Carrero, J. J., Dahlström, U., Anker, S. D., Lainščak, M., Hernandez, A. F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1757 · Cited by 68 · see citing works
Self-citationHyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD
Hussain, S., Khan, A. W., Akhmedov, A. T., Suades, R., Costantino, S., Paneni, F., Caidahl, K., Mohammed, S. A., Hage, C., Gkolfos, C., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317132 · Cited by 68 · see citing works
Late Graft Failure in Heart Transplant Recipients: Incidence, Risk Factors and Clinical Outcomes
López‐Sainz, Á., Barge‐Caballero, E., Barge‐Caballero, G., Couto‐Mallón, D., Paniagua-Martín, M. J., Quiroga, L. S., Iglesias‐Gil, C., Herrera-Noreña, J. M., Cuenca-Castillo, J. J., Vázquez‐Rodríguez, J. M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.886 · Cited by 68 · see citing works
Sharma, A., Demissei, B. G., Tromp, J., Hillege, H. L., Cleland, J. G. F., O’Connor, C. M., Metra, M., Ponikowski, P. P., Teerlink, J. R., Davison, B. A., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.912 · Cited by 64 · see citing works
Epidemiology of heart failure in diabetes: a disease in disguise
Hoek, A. G., Canto, E. D., Wenker, E., Bindraban, N. R., Handoko, M. L., Elders, P. J. M., & Beulens, J. W. J. (2024) · Diabetologia · doi:10.1007/s00125-023-06068-2 · Cited by 71 · see citing works
Epigenetic processing in cardiometabolic disease
Costantino, S., Mohammed, S. A., Ambrosini, S., & Paneni, F. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.029 · Cited by 64 · see citing works
Pei, Z., Deng, Q., Babcock, S. A., He, E. Y., Ren, J. T., & Zhang, Y. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.11.018 · Cited by 63 · see citing works
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules · doi:10.3390/biom12020176 · Cited by 62 · see citing works
Costantino, S., Paneni, F., Mitchell, K. J., Mohammed, S. A., Hussain, S., Gkolfos, C., Berrino, L., Volpe, M., Schwarzwald, C. C., Lüscher, T. F., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.082 · Cited by 62 · see citing works
Chen, Y., Wong, L. L., Liew, O. W., & Richards, M. (2019) · Cells · doi:10.3390/cells8121651 · Cited by 58 · see citing works
Thai, P. N., Miller, C., King, M. T., Schaefer, S., Veech, R. L., Chiamvimonvat, N., Bers, D. M., & Dedkova, E. N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020729 · Cited by 59 · see citing works
Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes
Standl, E., Schnell, O., & McGuire, D. K. (2016) · Circulation Research · doi:10.1161/circresaha.116.306924 · Cited by 59 · see citing works
Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus
Bahtiyar, G., Gutterman, D. D., & Lebovitz, H. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0809-4 · Cited by 59 · see citing works
Greene, S. J., Vaduganathan, M., Khan, M. S., Bakris, G. L., Weir, M. R., Seltzer, J. H., Sattar, N., McGuire, D. K., Januzzi, J. L., Stockbridge, N., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.047 · Cited by 56 · see citing works
Self-citationCauwenberghs, N., Knez, J., Thijs, L., Haddad, F., Vanassche, T., Yang, W., Wei, F., Staessen, J. A., & Kuznetsova, T. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008315 · Cited by 54 · see citing works
Comorbidities in Heart Failure: Are There Gender Differences?
Hopper, I., Kotecha, D., Chin, K. L., Mentz, R. J., & von Lueder, T. G. (2016) · Current Heart Failure Reports · doi:10.1007/s11897-016-0280-1 · Cited by 53 · see citing works
Self-citationNelson, A. J., Peterson, E. D., & Pagidipati, N. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.07.001 · Cited by 52 · see citing works
Butler, J., Handelsman, Y., Bakris, G. L., & Verma, S. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1708 · Cited by 52 · see citing works
Self-citationMechanisms of diabetic cardiomyopathy: Focus on inflammation
Bellemare, M., Bourcier, L., Iglesies‐Grau, J., Boulet, J., O’Meara, E., & Bouabdallaoui, N. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16242 · Cited by 56 · see citing works
Correale, M., Paolillo, S., Mercurio, V., Limongelli, G., Barillà, F., Ruocco, G. M., Palazzuoli, A., Scrutinio, D., Lagioia, R., Lombardi, C., et al. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.10.008 · Cited by 52 · see citing works
Mechanisms linking empagliflozin to cardiovascular and renal protection
Filardi, P. P., Avogaro, A., Bonora, E., Colivicchi, F., Fioretto, P., Maggioni, A. P., Sesti, G., & Ferrannini, E. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.089 · Cited by 50 · see citing works
Self-citationKhan, M. S., Felker, G. M., Piña, I. L., Camacho, A., Bapat, D., Ibrahim, N. E., Maisel, A. S., PRESCOTT, M. F., Ward, J. H., Solomon, S. D., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.09.014 · Cited by 50 · see citing works
Self-citationImproving Quality Outcomes: The Value of Diabetes Care and Education Specialists
Rodriguez, K., Ryan, D., Dickinson, J. K., & Phan, V. (2022) · Clinical Diabetes · doi:10.2337/cd21-0089 · Cited by 54 · see citing works
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
Rosengren, A., Edqvist, J., Rawshani, A., Sattar, N. A., Franzén, S., Adiels, M., Svensson, A., Lind, M., & Guðbjörnsdóttir, S. (2018) · Diabetologia · doi:10.1007/s00125-018-4700-5 · Cited by 49 · see citing works
Yu, Y.-W., Zhao, X.-M., Wang, Y.-H., Zhou, Q., Huang, Y., Zhai, M., & Zhang, J. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01209-y · Cited by 47 · see citing works
Diabetes and Heart Failure: Multi-Omics Approaches
Tayanloo-Beik, A., Roudsari, P. P., Rezaei–Tavirani, M., Biglar, M., Tabatabaei‐Malazy, O., Arjmand, B., & Larijani, B. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.705424 · Cited by 46 · see citing works
Huang, L., Yuan, P., Yu, P., Kong, Q., Xu, Z., Xia, Y., Shen, Y., Yang, J., Wan, R., Hong, K., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3866 · Cited by 46 · see citing works
Targher, G., Dauriz, M., Tavazzi, L., Temporelli, P. L., Lucci, D., Urso, R., Lecchi, G., Bellanti, G., Merlo, M., Rossi, A., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.207 · Cited by 45 · see citing works
Mehra, P., Guo, Y., Nong, Y., Lorkiewicz, P. K., Nasr, M., Li, Q., Muthusamy, S., Bradley, J. A., Bhatnagar, A., Wysoczynski, M., et al. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0703-0 · Cited by 44 · see citing works
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
Ferreira, J. P., Vasques‐Nóvoa, F., Ferrão, D., Saraiva, F. A., Falcão‐Pires, I., Neves, J. S., Sharma, A., Rossignol, P., Zannad, F. M., & Leite-Moreira, A. F. (2022) · Diabetes Care · doi:10.2337/dc21-1977 · Cited by 45 · see citing works
Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure
Doehner, W., Turhan, G., Leyva, F., Rauchhaus, M., Sandek, A., Jankowska, E., von Haehling, S., & Anker, S. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12035 · Cited by 37 · see citing works
Self-citationWin, T. T., Davis, H. T., & Laskey, W. K. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.003023 · Cited by 43 · see citing works
Kong, M. G., Jang, S. Y., Jang, J., Cho, H., Lee, S., Lee, S. E., Kim, K. H., Yoo, B., Kang, S., Baek, S. H., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01026-3 · Cited by 43 · see citing works
miR‑155 modulates high glucose‑induced cardiac fibrosis via the Nrf2/HO‑1 signaling pathway
Li, Y., Duan, J., He, Q., & Wang, C. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11495 · Cited by 41 · see citing works
Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices
Asleh, R., Briasoulis, Α., Schettle, S. D., Tchantchaleishvili, V., Pereira, N. L., Edwards, B. S., Clavell, A. L., Maltais, S., Joyce, D. L., Joyce, L. D., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004213 · Cited by 41 · see citing works
Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
Seferović, J. P., Solomon, S. D., & Seely, E. W. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820970444 · Cited by 40 · see citing works
Tran, S. K., Toan, N. H., Thang, N., Tuong, H. L. T., Tien, H. A., Thuy, N. H., Minh, H. V., & Valensi, P. E. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01509-5 · Cited by 42 · see citing works
Al-Hayali, M. A., Sözer, V., Durmuş, S., Erdenen, F., Altunoğlu, E., Gelışgen, R., Atukeren, P., Atak, P. G., & Uzun, H. (2019) · Biomolecules · doi:10.3390/biom9050193 · Cited by 39 · see citing works
Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
Wilkinson, M. J., Zadourian, A., & Taub, P. R. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.024 · Cited by 39 · see citing works
Alvarado‐Vásquez, N. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.05.010 · Cited by 39 · see citing works
Neves, J. S., Correa, S., Baptista, R. B., Vieira, M. B., Waikar, S. S., & Causland, F. R. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa017 · Cited by 40 · see citing works
New Management Strategies in Heart Failure
OWENS, A. T., Brozena, S. C., & Jessup, M. L. (2016) · Circulation Research · doi:10.1161/circresaha.115.306567 · Cited by 38 · see citing works
Lara-Rojas, C. M., Perez-Belmonte, L. M., Lopez-Carmona, M. D., Guijarro, R., Bernal-López, M. R., & Gómez‐Huelgas, R. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.04.005 · Cited by 36 · see citing works
Campbell, P. T., Krim, S. R., & Ventura, H. O. (2015) · Cardiac failure review · doi:10.15420/cfr.2015.01.01.8 · Cited by 35 · see citing works
Hanff, T. C., Cohen, J. B., Zhao, L., Javaheri, A., Zamani, P. L., Prenner, S. B., Rietzschel, E. R., Jia, Y., Walsh, A. M., Maranville, J., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.11.011 · Cited by 34 · see citing works
Papadaki, M., Kampaengsri, T., Barrick, S. K., Campbell, S. G., von Lewinski, D., Rainer, P. P., Harris, S. P., Greenberg, M. J., & Kirk, J. A. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.012 · Cited by 33 · see citing works
Gao, H., Hou, F., Dong, R., Wang, Z., Zhao, C., Tang, W., & Wu, Y. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12206 · Cited by 32 · see citing works
Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus
Vijayakumar, S., Vaduganathan, M., & Butler, J. (2018) · Circulation · doi:10.1161/circulationaha.117.032099 · Cited by 32 · see citing works
Self-citationYu, M., Sun, Y., Shan, X., Yang, F., Chu, G., Chen, Q., Han, L. G., Guo, Z., & Wang, G. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00379-9 · Cited by 32 · see citing works
Sonaglioni, A., Cerini, F., Fagiani, V., Nicolosi, G. L., Rumi, M. G., Lombardo, M., & Muti, P. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082690 · Cited by 35 · see citing works
Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
Pradhan, A. K., Vohra, S., Vishwakarma, P., & Sethi, R. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_232_19 · Cited by 30 · see citing works
Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice
Loi, H., Крамар, С., Laborde, C., Marsal, D. J., Pizzinat, N., Cussac, D., Roncalli, J. G., Boal, F., Tronchère, H., Oleshchuk, O., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179393 · Cited by 30 · see citing works
Fu, E. L., Patorno, E., Everett, B. M., Vaduganathan, M., Solomon, S. D., Levin, R., Schneeweiß, S., & Desai, R. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad273 · Cited by 30 · see citing works
Abdul-Rahim, A. H., MacIsaac, R. L., Jhund, P. S., Petrie, M. C., Lees, K. R., & McMurray, J. J. V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.074 · Cited by 29 · see citing works
Shailendra, P. S., Ja, M., Bellner, L., Cao, J. J., Waldman, M., Schragenheim, J., Arad, M., Hochhauser, E., Falck, J. R., Weingarten, J. A., et al. (2018) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000233 · Cited by 28 · see citing works
Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus.
Sharma, A. K., Cooper, L. B., Fiuzat, M., Mentz, R., Ferreira, J., Butler, J., Fitchett, D., Moses, A., O'Connor, C., & Zannad, F. (2018) · JACC. Heart failure · doi:10.1016/j.jchf.2018.05.020 · Cited by 27 · see citing works
Self-citationSudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?
Vaduganathan, M., Patel, R. B., Shah, S. J., & Butler, J. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9525-z · Cited by 29 · see citing works
Self-citationKhalil, C. A., Sulaiman, K., Singh, R., Jayyousi, A., Asaad, N., AlHabib, K. F., Alsheikh-Ali, A. A. A., Al‐Jarallah, M., Bulbanat, B., Almahmeed, W. A., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.119 · Cited by 28 · see citing works
Value of the CHA2DS2-VASc Score for Predicting Outcome in Patients with Heart Failure
Shuvy, M., Zwas, D. R., Keren, A., & Gotsman, I. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12831 · Cited by 29 · see citing works
Hirose, K., Nakanishi, K., Daimon, M., Sawada, N., Yoshida, Y., Iwama, K., Yamamoto, Y., Ishiwata, J., Hirokawa, M., Koyama, K., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01201-6 · Cited by 28 · see citing works
Belli, M., Barone, L., Bellia, A., Sergi, D., Lecis, D., Prandi, F. R., Milite, M., Galluccio, C., Muscoli, S., Romeo, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314598 · Cited by 29 · see citing works
Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?
Lee, H., & Oh, B. (2020) · International Journal of Heart Failure · doi:10.36628/ijhf.2020.0010 · Cited by 28 · see citing works
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management
Mancini, G. B. J., CHENG, A. Y. Y., Connelly, K. A., FITCHETT, D. H., Goldenberg, R., Goodman, S. G., Leiter, L. A., Lonn, E., Paty, B. W., Poirier, P., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.512 · Cited by 27 · see citing works
Zhang, X., Liu, F., Li, W., Zhang, J., Zhang, T., Yu, X., Luo, J., Zhao, Q., Zhang, J., Fang, B., et al. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s404878 · Cited by 27 · see citing works
Diabetes mellitus and congestive heart failure
Serhiyenko, V. A., & Serhiyenko, A. A. (2022) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.18.1.2022.1146 · Cited by 26 · see citing works
- Authors
- Dei Cas, A., Khan, S. S., Butler, J., Mentz, R. J., Bonow, R. O., Avogaro, A., Tschoepe, D., Doehner, W., Greene, S. J., Senni, M., Gheorghiade, M., & Fonarow, G. C.
- Affiliations
- Northwestern University (US)
- Stony Brook University (US)
- Duke Medical Center (US)
- University of Padua (IT)
- University Hospitals of the Ruhr-University of Bochum (DE)
- Center for Stroke Research Berlin (DE)
- Ospedale Papa Giovanni XXIII (IT)
- University of California, Los Angeles (US)
- Corresponding author
- Fonarow, Gregg C.
- ORCID
- Venue
- JACC Heart Failure
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 3
- Issue
- 2
- Pages
- 136-145
- ISSN
- 2213-1779 (ISSN-L)
- OpenAlex
- W2072535229
- Cited by
- 401
- References
- 59
- Citations by year
- 2026: 8 · 2025: 28 · 2024: 33 · 2023: 17 · 2022: 55 · 2021: 69 · 2020: 55 · 2019: 31 · 2018: 40 · 2017: 20 · 2016: 26 · 2015: 19
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- JACC Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Amgen
- Boston Scientific Corporation
- National Institutes of Health
- Agency for Healthcare Research and Quality
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- heart failure, diabetes mellitus, comorbidities, prevalence, pathophysiology, metabolic abnormalities, treatment outcomes, targeted therapy
- MeSH terms
- Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Autonomic Nervous System Diseases, Diabetes Mellitus, Diuretics, Fatty Acids, Nonesterified, Heart, Heart Failure, Humans, Insulin Resistance, Mitochondria, Heart, Myocardium, Renin-Angiotensin System, Renal Insufficiency, Vascular Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
